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The glycation (nonenzymatic glycosylation) of sev- 
eral proteins  was  studied  in  various  buffers in order  to 
assess the  effects of buffering ions on the  kinetics  and 
specificity of glycation of protein. Incubation of RNase 
with glucose in phosphate buffer  resulted in inactiva- 
tion of the enzyme because of preferential modification 
of lysine residues  in or near  the  active site. In contrast, 
in the cationic buffers, 3-(N-morpholino)propane- 
sulfonic acid and 3-(N-tris(hydroxymethyl)rnethyl- 
amino)-2-hydroxypropanesulfonic acid, the  kinetics of 
glycation of RNase were decreased 2-  to 3-fold, there 
was a decrease in glycation of active  site versus pe- 
ripheral lysines, and  the enzyme was  resistant  to  in- 
activation by glucose. The  extent of Schiff base for- 
mation on RNase was comparable in  the  three  buffers, 
suggesting that phosphate, bound in the  active  site of 
RNase, catalyzed the Amadori rearrangement at active 
site lysines, leading to  the enhanced rate of inactiva- 
tion of the enzyme. Phosphate  catalysis of glycation 
was  concentration-dependent  and could be mimicked 
by arsenate.  Phosphate also stimulated the rate of gly- 
cation of other  proteins, such as lysozyme, cytochrome 
c, albumin, and hemoglobin. As with RNase, phosphate 
affected the specificity of glycation of hemoglobin, re- 
sulting  in  increased glycation of amino-terminal  valine 
versus intrachain  lysine residues. 2,3-Diphosphogly- 
cerate  exerted  similar  effects on the glycation of hemo- 
globin, suggesting that inorganic and organic phos- 
phates may play an  important  role in determining  the 
kinetics  and specificity of glycation of hemoglobin in 
the  red cell. Overall,  these  studies  establish that buff- 
ering ions or ligands  can exert significant  effects on 
the  kinetics  and specificity of glycation of proteins. 
Nonenzymatic glycosylation or glycation is  a common post- 
translational modification of proteins  in the body (l), result- 
ing from reaction between glucose and  the amino groups on 
protein. Glycation proceeds through formation of a Schiff 
base intermediate, followed  by an Amadori rearrangement to 
yield a relatively stable ketoamine adduct to  the protein (cf. 
Fig. 6 under “Discussion”) (2, 3). Although nucleophilic, low 
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pKa amino groups, e.g. the  a-amino groups on protein, should 
be most reactive in forming Schiff base adducts, it is now 
recognized that other factors beside the pKa of the amino 
group determine the final distribution of ketoamine adducts 
to proteins. Thus, for hemoglobin (Hb),’ despite the similar 
pK. values of the valine residues at  the termini of the a- and 
@-chains (4), the @-chain valines are about 10 times more 
reactive with glucose both in vivo and in vitro (5). Similarly, 
we have observed (6) that although Nu-Lys-1 was the primary 
site of formation of Schiff base adducts to ribonuclease 
(RNase),  other amino groups, including IF-Lys-1, were up to 
10 times more reactive in forming ketoamine adducts. 
Some progress has been made in identifying factors affect- 
ing the specificity of glycation of proteins. Shapiro et al. (5) 
noted increased glycation of lysine residues adjacent to acidic 
amino acids in Hb, suggesting that  the carboxyl groups of 
adjacent aspartate  or glutamate residues could serve as neigh- 
boring group, intramolecular catalysts of the Amadori rear- 
rangement. Lysines 1 and 37 are adjacent to acidic amino 
acids in RNase and were also among the more reactive sites 
of glycation of this  protein (6). Studies with Hb (5), human 
serum albumin (7,  8), and lysozyme’ have shown that the 
lysine residues in Lys-Lys and other basic amino acid se- 
quences are more  highly glycated than other lysines in these 
proteins. In recent work on the glycation of RNase (6,9), we 
showed that  the reactive lysine residues in this enzyme  were 
located in  or  near the phosphate binding region of the active 
site,  a fairly basic region of the protein, rich in lysine, histi- 
dine, and arginine residues. Since our experiments were done 
in phosphate buffer, we suggested that some of the specificity 
of glycation of RNase might derive from the binding of 
phosphate ions, which could serve as  a local catalyst of the 
Amadori rearrangement on lysine residues in or near the 
active site. In this paper we describe the effects of phosphates 
on the kinetics and specificity of glycation of RNase and 
several other  proteins  and  present  a general theory on how 
buffering ions and ligands affect the kinetics and specificity 
of glycation of proteins. 
EXPERIMENTAL PROCEDURES 
Materials-RNase A (Type XII-A), horse heart cytochrome c 
(Type VI), chicken egg white lysozyme (Grade I), human serum 
albumin, sodium borohydride, sodium cyanobomhydride, 2,3-diphos- 
phoglycerate (DPG), MOPS, and TAPSO were obtained from Sigma. 
D-Glucose was purchased from P-L Biochemicals, and [3H]sodium 
The abbreviations used are: Hb, hemoglobin; DPG, 2,3-diphos- 
phoglycerate; MOPS, 3-(N-morpholino)propanesulfonic acid; RNase, 
bovine pancreatic ribonuclease; TAPSO, 3-(N-tris(hydroxymethyl)- 
methylamino)-2-hydroxypropanesulfonic acid; HPLC, high pressure 
liquid chromatography. 
C. J. Hull, S. R. Thorpe, and J. W. Baynes, unpublished obser- 
vations. 
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borohydride and D-[6-3H]glucose from Du Pont-New  England  Nu- 
clear. Radioactive glucose was purified by column chromatography 
on Aminex HPX-87C (Bio-Rad), as described previously (6). [3H]- 
Glucitolvaline was prepared by incubating  D-[6-3H]glucose  (250  pCi, 
0.1 M) with  L-valine (0.1 M) in the presence of Na13H3CN  (0.2 M) in 
0.2 M phosphate  buffer  for 3 days at 37 "C. Excess NaBH3CN was 
discharged by addition of 1 N HC1 to pH 3, and the product  isolated 
by cation  exchange  chromatography, as described by Schwartz and 
Gray (10). 
Glycatwn of Proteins-General  procedures  for  glycation f proteins 
and characterization of products were as described previously for 
RNase (6). Briefly, proteins (25  mg/ml)  were  incubated  with 0.4 M 
glucose in 0.2 M buffer (phosphate, MOPS, or TAPSO), pH 7.4, 
containing 3 mM sodium  azide. Solutions were preincubated  for 1 h 
at 37  "C, the pH  readjusted to 7.4, as needed, and the reaction  mixture 
sterilized by filtration through a Gelman  0.2-pm filter (Acrodisc) into 
a sterile 1.5-ml plastic centrifuge tube (Sarstedt). Aliquots were 
removed at various  times and frozen at -20 "C until assayed. 
Measurement of Glucose  Adducts  to  Protein-For measuring  Schiff 
base adducts to RNase, the protein was incubated for 3 h with 
radioactive glucose, a sufficient time to achieve  Schiff  base  equilib- 
rium (ll), but prior to extensive ketoamine modification on the 
protein. The reaction  mixture was then cooled  on  ice, and an aliquot 
(100 al, 2 mg  of protein) was fractionated by  gel  exclusion chroma- 
tography on a 0.5 X 30 cm column of Sephadex G-25 (Pharmacia) 
equilibrated  in 0.1 M Tris-C1  buffer,  pH 7.4. The chromatography was 
conducted at low temperature to minimize  dissociation of  Schiff  base 
adducts, and the extent of  Schiff  base formation  calculated from the 
specific activity of the glucose and the glucose radioactivity and 
protein content of the void  volume fractions, as described  previously 
(11). Glucose concentration was measured by a glucose oxidase- 
peroxidase  assay  (Amresco) and protein concentration by absorbance 
at 280  nm. Corrections were applied  for the limited extent of ketoa- 
mine  formation during the incubation  period.  For  measurement of 
ketoamine  adducts to RNase and other proteins, an aliquot of the 
reaction  mixture was diluted to 1 ml  with  0.1 N sodium acetate, pH 
5, incubated at 37  'C  for 1 h in  order to discharge  Schiff  base adducts 
(121, then chromatographed, and analyzed as above. Procedures  for 
labeling  glycated  RNase by reduction  with [3H]NaBH4 (6), for  sepa- 
rating the tryptic peptides of RNase by reversed-phase HPLC (6), 
and conditions  for NMR spectrometry (13,14) have  been  described. 
Glycation of Valine Versus Lysine Residues in Hemoglobin-Hb 
was isolated following  hemolysis  of saline-washed  human  red  cells in 
2 volumes  of distilled water for 1 h at room temperature. The 
hemolysate  was centrifuged  for 20  min at 10,000 X g to remove  cell 
membranes, and the supernatant was  gassed  with  carbon  monoxide. 
Hb-CO  concentration was determined by absorbance at 540  nm ( E d  
= 13.4) (15).  Aliquots of this solution were then diluted 100-fold into 
0.2 M incubation  buffer  (phosphate,  TAPSO, or TAPSO  plus  10 mM 
DPG, pH  7.4),  containing 0.4 M glucose, and incubated at 37  "C under 
a CO, atmosphere.  After  incubation, the protein solution was  dialyzed 
against phosphate-buffered saline to remove free glucose, then re- 
duced  with [3H]NaBH,.  Excess borotritide was destroyed and heme 
simultaneously extracted by addition of 20 volumes of  0.25 M HCl in 
acetone (16). Globin  was isolated by centrifugation, then hydrolyzed 
and analyzed  for its hexitolvaline and hexitollysine content by cation 
exchange  chromatography, as previously  described (6, 14). 
RESULTS 
To evaluate  the  effects of phosphate  on  the specificity of 
glycation of RNase, we compared  reactions in phosphate  with 
those  in  MOPS (17) and  TAPSO (18), which  have pK, values 
similar  to  phosphate (7.2 and 7.4 at 37 "C, respectively), but 
are  cationic,  rather  than  anionic buffers. As shown  in Fig. LA, 
the kinetics of glycation of RNase, i.e. the  rate of formation 
of the  ketoamine  adduct,  varied  significantly  with the nature 
of the  buffering species. The kinetic  differences were maximal 
at  early  times,  but  even  after 1 week of incubation  the  rate of 
reaction  was  measurably  faster  in  phosphate  than  in  MOPS 
or  TAPSO.  The  slight  difference  in  rate  between MOPS and 
TAPSO was  reproducible, and the slowest rates of glycation 
were  consistently  obtained in TAPSO buffer. The  pH of the 
reaction  mixtures  was  checked regularly in  these  experiments 
using a microelectrode (Lazar Research, model 1416) and 
0 3 6 9 12 
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FIG. 1. Effect of buffering ions on the kinetics of glycation 
and inactivation of RNase. RNase was incubated with 0.4 M 
glucose in  each of the three buffers (0.2 M) at pH 7.4 and samples 
removed at indicated times for assay. A,  the extent of glycation 
(formation of the ketoamine adduct) was  measured  by chromatogra- 
phy  on  Sephadex  G-25 after mild  acid treatment to discharge  Schiff 
base  adducts, as described  under  "Experimental  Procedures." B, the 
percent of initial specific  enzymatic  activity of  RNase  was determined 
using  yeast  RNA as substrate (19). 
required occasional adjustment with 1 N NaOH during  the 
first few days.  However, pH  drift  never exceeded 0.1 pH  units 
so that the kinetic differences were not the result of pH 
variations in the  three  buffer  systems. 
As shown  in Fig. lB, the  kinetics of inactivation of RNase 
were also significantly different in the three buffers. The 
enzyme lost about 35% of its  activity  after glycation with 1 
mol of Glc/mol of protein in phosphate buffer, i.e. after 3 
days' reaction. In contrast,  RNase glycated to the  same  extent 
in  MOPS  or TAPSO buffer, i.e. after  incubation  for 1-2 weeks, 
retained  essentially 100% of its original  enzymatic activity. 
The reason  for  the  initial  increase  in  RNase  activity  in  the 
MOPS and TAPSO incubations  is  unknown,  but it was ob- 
served  consistently  in  separate  experiments.  Since  the  inac- 
tivation of RNase  by glucose in  phosphate  buffer  was associ- 
ated with glycation of lysine residues  in  or  near  the  active  site 
(6), the  results  in Fig. 1 suggested that the decreased rate of 
glycation and inactivation of RNase  in  cationic  buffers  might 
be  associated  with  alterations  in  the  sites of glycation of the 
enzyme. 
The  tryptic  peptide  maps,  shown  in Fig. 2, indicated  that 
the  pattern of modification of RNase is significantly  different 
in phosphate versus TAPSO buffer, with  the  peptide  map  in 
MOPS being nearly identical to that in TAPSO (data not 
shown). Notably, no new labeled peptides appeared in the 
MOPS or  TAPSO  chromatograms,  but clearly, compared to 
Lys-37, the  relative  extent of glycation of Lys-1, 7, and  41 
was  significantly  increased  in  phosphate uersus MOPS  and 
TAPSO buffers. Although Lys-37 was the primary site of 
glycation of RNase  in  the  cationic buffers, its  absolute  rate of 
modification was similar  in  all  three buffers, i.e. about 3% per 
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FIG. 2. Tryptic peptide maps of RNase glycated in phos- 
phate and TAPSO buffers. RNase was incubated with 0.4 M 
glucose  in either phosphate (top) or TAPSO  (bottom)  buffer  for 3 or 
14 days,  respectively, in order to obtain  glycation  with 1 mol of Glc/ 
mol of protein.  After  discharging  Schiff  base  adducts and dialysis, 
glycated protein was reduced with [3H]NaE3H,, oxidized with per- 
formic acid, then digested with trypsin. The tryptic peptides were 
resolved by reversed-phase HPLC (6). The labels over the peaks 
identify the sequence  number of the lysine  residue  glycated in each 
peptide.  These  procedures and the identification of the lysine  residues 
were reported in detail previously (6). 
day. Thus, RNase glycated for 3 days in phosphate buffer 
contained 1 mol of Glc/mol of RNase,  and Lys-37 accounted 
for 8.4%  of the  total  peptide  radioactivity (Fig. 2 A ) ,  i.e. -2.8% 
glycation of Lys-37 per  day  in  phosphate buffer.  Although a 
14-day  incubation period  was  required to  obtain 1 mol of Glc/ 
mol of RNase  in  TAPSO buffer,  Lys-37 accounted for 40.6% 
of peptide radioactivity in  this  preparation (Fig. ZB), yielding 
-2.9% glycation of Lys-37 per day, i.e. the  same  rate  as  in 
phosphate buffer. In  contrast, by a similar  analysis  there was 
about a 10-fold increase in the  rate of modification of Lys-1 
and  41  in  phosphate versus TAPSO  and  about a 4-fold in- 
crease  in glycation of Lys-7. The  constant  reactivity of Lys- 
37  with glucose in  the  various buffers is probably attributable 
to  catalytic effects of the  adjacent Asp-38  residue (5), inde- 
pendent of the buffering species. Analysis of the hexitollysine 
isomers  from  RNase glycated in  phosphate buffer yielded 15% 
N“-hexitollysine  in  the  protein (6); however, only traces 
(<3%) of Nu-hexitollysine were detectable  in  RNase glycated 
in  MOPS  or  TAPSO (data not  shown). The overall increase 
in glycation of Lys-1  in  phosphate  indicated  that  phosphate 
stimulated  the glycation of both  the a- and  t-amino groups of 
Lys-1. The  results of the  peptide  and hexitollysine analyses 
were confirmed by 13C-NMR spectroscopy. As shown in Fig. 
3, resonances assigned to the anomeric carbons of glucose 
adducts  to  Ne-Lys-1  and  W-Lys-41 (14) were absent  from  the 
spectrum of RNase glycated in either MOPS or TAPSO. 
Overall, the  peptide  mapping  and  NMR  results  indicate  that 
phosphate stimulates the glycation of Lys-1, 7, and 41 in 
RNase  but does not  affect  the glycation of Lys-37. 
Phosphate ions could affect the kinetics or specificity of 
glycation of RNase  either by altering  the equilibrium concen- 
tration of Schiff base  adducts at various  sites  on  the  protein 
or by differential  catalysis of the Amadori rearrangement at 
these sites. To  determine  the  effect of phosphate  on Schiff 
base formation, the protein was incubated with glucose for 
short  periods of time,  and  the  concentration of Schiff base 
adducts was measured by gel exclusion chromatography a t  
low temperature (11). These data were used to derive an  
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FIG. 3. Anomeric region of Carbon-13 NMR spectra of 
RNase glycated in various buffers. RNase was incubated with 
[2-’3C]glucose  in  various  buffers to obtain  modification  with 1 mol  of 
glucose/mol  of  RNase.  NMR spectra were  acquired on a Bruker  WH- 
400 NMR spectrometer under conditions previously described (13, 
14). Sets of three resonances (a- and  8-furanose  and  &pyranose)  are 
observed  for the anomeric  carbon of  glucose adducts to each of the 
three  types of amino  groups  in  RNase (20): a = N”-Lys-l, pK. - 7.5; 
* = N’-Lys-41, pK. - 8.8; and c = peripheral t-amino groups, pK. 
-10.5. 
TABLE I 
Effect of buffers on formation of Schiff base  adducts to RNase 
All incubations were  conducted in 0.2 M buffer,  pH 7.4, for 3 h and 
analyzed  for  Schiff  base  and  ketoamine content as described  under 
“Experimental  Procedures.” The amount of ketoamine  adduct was 
less than 10% of  Schiff  base content in all  three  incubations. 
Buffer Schiff base Estimated K-0 





TAPSO  0.62 1.6 
The rC, was determined using the equation, Glc + RNase + 
Glc=RNase, where Glc=RNase refers to the Schiff base adduct to 
RNase. 
tween glucose and  RNase, i.e. a composite K ,  for all  amino 
groups in  the enzyme. As shown in  Table I, the equilibrium 
constant  for Schiff base  formation  did  not vary  greatly among 
the  three buffers, and was, in  fact,  somewhat higher in  MOPS 
and  TAPSO  than  in  phosphate,  despite  the more rapid overall 
rate of glycation in  phosphate. The  data  indicate  that in 0.4 
M glucose at pH 7.4 more than half of the  protein molecules 
contain glucose in the form of a Schiff base adduct. As 
reported previously (61, the  primary  site of Schiff  base  for- 
mation  is at the  a-amino  group of Lys-1, whereas,  regardless 
of the  buffers used, the  pattern of glycation of the  protein 
indicates  that  other  sites  are more  reactive in undergoing the 
Amadori rearrangement. Clearly, the slow step in the glyca- 
tion  reaction  is  the Amadori rearrangement,  and  phosphate 
appears  to  exert  its effect by catalysis of this  reaction. 
As shown  in  Table 11, the  phosphate ffect is concentration- 
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TABLE I1
Clycation of RNase in various  buffers 
RNase was  incubated with 0.4 M glucose  for 3 days in the various 




0.2 M phosphate 1.02 
0.2 M TAPSO 0.33 
0.2 M TAPSO + 0.01 M phosphate 0.38 
0.2 M TAPSO + 0.05 M phosphate 0.62 
0.2 M TAPSO + 0.2 M phosphate 1.01 
0.2 M TAPSO + 0.2 M arsenate 1.56 
0.2 M TAPSO + 0.2 M NaCl 0.29 
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FIG. 4. Kinetics of glycation of various  proteins  in phos- 
phate versus TAPSO buffer. Incubations and analyses were  car- 
ried out as described in the legend to Fig. 2. 
dependent, with an indication that half-maximal stimulation 
is achieved at about 50 mM phosphate concentration. This is 
remarkably close to the dissociation constant for phosphate 
binding to RNase, estimated  as -40 mM (20). Arsenate, which 
is anionic and similar in geometry and pK, to phosphate, was 
more  effective than phosphate  as  a  catalyst of glycation, but 
it is not clear whether this  results from a difference in binding 
affinity or the slight, 0.4-unit decrease in the pK, of arsenate 
versus phosphate. In  a control experiment, the addition of  0.2 
M NaCl, a nonbuffering salt at neutral  pH, had no effect on 
the rate of glycation in TAPSO buffer (Table 11). 
The experiments described thus far have focused on the 
analysis of buffer effects on glycation of a model protein, 
RNase, which has a well-characterized phosphate-binding 
site. We had expected that  the kinetics of glycation of proteins 
without unique phosphate-binding  sites would be relatively 
insensitive to buffer effects. As shown in Fig. 4, however, 
whereas the magnitude of buffer effects on glycation vaned 
with different proteins, phosphate  stimulated the glycation of 
all proteins studied. The greatest effects were noted with very 
basic proteins such as RNase, lysozyme, and cytochrome c,  
while less pronounced effects were seen with more acidic 
proteins such as albumin and Hb. 
The glycation of Hb was studied in greater detail by assess- 
ing buffer and ligand effects on the specificity of glycation of 
amino-terminal valine versus intrachain lysine residues in 
this protein. Hb was reacted with non-radioactive glucose for 
3 days in various buffer systems, and the distribution of 
glucose between valine and lysine residues was quantitated 
by reduction with [3H]NaBH4  and measurement of radioac- 
tivity in hexitolvaline and hexitollysine fractions. Fig. 5, A-C 
shows the results obtained on glycation of Hb in 0.2 M 
TAPSO, 0.2 M phosphate,  and 0.2 M phosphate containing 10 
mM DPG, respectively. In agreement with kinetic data in Fig. 
4, comparison of Fig. 5, A and B, indicates an approximate 
2.5-fold increase in glycation of Hb in phosphate versus 
TAPSO buffer. Although phosphate increased the overall 
extent of glycation of both valine and lysine residues in  the 
protein, there was also a significant and reproducible increase 
in the relative extent of glycation of valine residues. In 
TAPSO the ratio of hexitolvaline to hexitollysine in Hb was 
1:16 (8.4% hexitolvaline), whereas in phosphate  the  ratio was 
1% (12.6% hexitolvaline). We reasoned that phosphate might 
exert selective enhancement of valine glycation through its 
binding in the allosteric, DPG-binding site of Hb, which 
includes the @-chain amino-terminal valine residues. To study 
possible effects of the  natural ligand, DPG, on glycation of 
Hb, the protein was also glycated in TAPSO buffer in the 
presence of DPG. The concentration chosen, 10 mM, was at 
the upper limit of the physiological range of organic phosphate 
concentration  in the red cell (21). As can be seen in Fig. 5C, 
even at low concentrations  in  TAPSO buffer, DPG exerted a 
significant effect on the kinetics of glycation of both valine 
and lysine residues in Hb (Fig. 5, C versus A ) .  In addition, the 
relative extent of glycation of valine residues was even further 
increased, compared to both the TAPSO  and  phosphate  in- 
cubations, i.e. hexitolvaline/hexitollysine = 15, or 17.1% hex- 
itolvaline. These results are  consistent with both  a general 
effect of DPG on the glycation of both valine and lysine 
residues in Hb, as well as a selective enhancement of the 
glycation of valine residues. Further studies are now in prog- 
ress to evaluate the concentration dependence of phosphate 
and  DPG effects on the kinetics and specificity of glycation 
of both valine and lysine residues in hemoglobin. 
DISCUSSION 
Glycation is an early step in a complex series of Maillard 
of browning reactions which occur between reducing sugars 
and  proteins or other amines (1,22,23). Phosphate is known 
to enhance the overall rate of this reaction, as measured by 
the kinetics of development of brown  color or fluorescence 
(24,25).  Phosphate also increases the proportion of the open 
chain, reactive form of reducing sugars in solution (26) and 
TIME ( m i d  
FIG. 5. Specificity of glycation of hemoglobin in various 
buffer systems. In each case hemoglobin  was  glycated  for 3 days in 
0.4 M glucose. After acid treatment and dialysis, proteins (200 pg) 
were  reduced with [3H]NaBH,. Following  acid  hydrolysis,  equal 
amounts of  protein  were fractionated on an  amino acid analyzer  and 
fractions assayed for radioactivity. A, Hb  glycated in 0.2 M TAPSO. 
B,  Hb  glycated in 0.2 M phosphate. C, Hb  glycated in 0.2 M TAPSO 
buffer containing 10 mM DPG. HV, hexitolvaline; ML, W-mannitol- 
lysine; GL, W-glucitollysine. 
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FIG. 6. Reaction  pathway  for  glycation  of  protein,  showing 
the  catalytic effect of  phosphate  bound  in a  basic  microenvi- 
ronment in the  structure of a  protein. The mechanism for catal- 
ysis by phosphate is adapted from Refs. 2 and 3. The hypothetical 
phosphate-binding microenvironment consists of an array of a t  least 
2 basic residues. The binding site may be small, such as a Lys-Lys 
sequence (including the lysine residue to be glycated), or a larger 
feature of a protein,  such as  the active site of RNase or allosteric site 
of Hb. The effect of phosphate on the specificity of glycation is 
achieved by its binding and function as a neighboring group catalyst 
of glycation in specific microenvironments of the protein. 
promotes the enolization of sugars in solution (27). Since its 
pK, is  near  neutral  pH,  phosphate  can also serve as  an acid- 
base catalyst of numerous reactions under physiological con- 
ditions, including the Amadori rearrangement. Thus,  it was 
not  surprising that  this ion, which can affect sugar structure 
and reactivity, would affect the kinetics of glycation of protein 
in a  concentration-dependent fashion. The unexpected obser- 
vation in this work  was that inorganic and organic phosphate 
also altered the specificity of modification of proteins by 
glucose.  We conclude that  the effectiveness of phosphate  as  a 
catalyst of glycation is promoted by its binding to unique, 
basic microenvironments in proteins (Fig. 6), and that the 
specificity of phosphate binding affects the specificity of 
glycation of protein. Thus,  preferential glycation of lysines in 
or near the active site of RNase and of 8-chain-terminal 
valine residues in Hb can be explained by the binding of 
phosphate  in the active and allosteric sites of these  proteins, 
respectively. While we have not shown conclusively at  this 
point that phosphate catalyzes only glycation of the  8-chain 
valines in  the allosteric site of Hb, leading to  the formation 
of HbAre (1,5), this is likely, based on analogies between the 
phosphate-binding sites of RNase and Hb (28). Like the 
reactive lysines of RNase, the P-chain valines of Hb are 
located in a basic cleft or cavity in the protein. These regions 
in RNase and  Hb have a  functional role in the binding of 
phosphorylated molecules, i.e. the substrate, RNA, or the 
allosteric effector, DPG, respectively. The effects of phos- 
phate on the specificity of glycation of these  proteins suggest 
that organic phosphate-binding active and allosteric sites may 
also be reactive sites for glycation of other proteins and 
enzymes. 
Since DPG exerts such a pronounced effect on both the 
overall kinetics and  the specificity of glycation of Hb in uitro 
(Fig. 5, C uersus A )  the binding of organic phosphates to Hb 
is probably also significant in  determining the  rate  and  pat- 
tern of glycation of the protein in uiuo. Several investigators 
(29-31) have described strong positive correlations between 
DPG  concentration  and the kinetics of formation of  HbAI, in 
vivo and in  uitro. Our results  support  these observations by 
showing that both  phosphate  and  DPG  enhance the  rate of 
glycation of the P-chain valine residues of Hb in uitro. Smith 
et al. (29) also noted increased rates of HbAI, formation in 
vitro when red cells were deoxygenated, an observation which 
might now be explained, in  part, by the increased binding of 
DPG to deoxyhemoglobin (15). In addition to effects on 
glycation of valine, it is apparent in Fig. 5 that phosphate and 
DPG also alter  the kinetics, and possibly the specificity, of 
glycation of lysine residues in Hb. Effects on glycation of 
lysine might result, for example, from  weak binding of DPG, 
as well as  phosphate to microenvironments on the surface of 
hemoglobin. Indeed, the ratio of valine to lysine glycation in 
the presence of 10 mM DPG (Fig. 5c, 17% valine) is signifi- 
cantly different from that observed in TAPSO buffer alone 
but closer to  that observed for Hb in uiuo (26% valine) by 
Bunn et al. (32). Our results do not exclude competing or 
complementary roles for both organic and inorganic phos- 
phate since the concentration of free phosphate  in the red 
cell, -0.5 mM (21), is sufficiently high, e.g. relative to the 
binding constant for phosphate to hemoglobin (Kd - 1 mM) 
( 3 3 ,  that fractional  saturation of the DPG-binding site with 
phosphate is also likely. The effects of phosphates may not 
be limited to reactions between glucose and  Hb, since Acharya 
et al. (34, 35) have shown that glyceraldehyde forms Schiff 
base adducts equally with Val-l(a)  and Val-l(j3) in Hb, wheras 
Amadori adducts  are formed at least 20 times more rapidly at 
Val-1(/3) than Val-1(a) in phosphate buffer. 
Besides amino groups in or near high-affinity phosphate- 
binding sites  in  proteins lysine residues in Lys-Lys or other 
basic sequences have also been identified as reactive site for 
glycation of Hb (5), albumin (7, 8), and lysozyme.* In recent 
work  on the glycation of albumin, which appeared while this 
paper was in preparation, Iberg and Fluckiger (8) noted that 
lysine residues glycated in albumin were frequently located in 
such sequences of basic amino acids and suggested that clus- 
ters of basic amino acids in protein may act  as neighboring 
group catalysts of the Amadori rearrangement on adjacent 
lysine residues. Our observations suggest that  the catalysis of 
the Amadori rearrangement in basic microenvironments is 
more  likely to result from the binding of phosphate, bicarbon- 
ate, or other buffering ions in body fluids and  that  the buff- 
ering milieu and  the protein’s structure  are equally important 
in determining the specificity of glycation of proteins in vivo 
and in vitro. Once the glycation reaction is completed, the 
continued binding of anionic buffering ions in the vicinity of 
the Amadori adduct may also serve to catalyze further brown- 
ing and cross-linking reactions characteristic of the later 
stages of the Maillard reaction. Additional studies on the 
specificity of glycation of proteins  in anionic versus cationic 
buffers may provide insights  into the distribution of anion- 
binding sites on proteins  and  their possible role in  the brown- 
ing stages of the Maillard reaction. 
Finally, as a cautionary note, the observation of buffer- 
dependent specificity of glycation suggests that proteins gly- 
cated in “physiological buffers” in vitro may not always be 
good  models for the same proteins glycated in uiuo. Shapiro 
et al. (5) have reported differences in the  pattern of glycation 
of lysine residues in  Hb glycated in  vitro uersus in uiuo, which 
might be attributable to differences in their buffer system 
(Krebs-Ringer phosphate) uersus the milieu interieur of the 
red cell. Our results emphasize that  the  pattern of glycation 
of proteins glycated in  vitro should be compared to  that of the 
naturally glycated protein before drawing conclusions regard- 
ing the relevance of glycation in  vitro to effects on the  struc- 
tural  and functional properties of the protein in uiuo. 
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